4/A//SEC Filing
Gutteridge Mike 4/A
Accession 0001251769-22-000023
CIK 0001251769other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:53 PM ET
Size
8.3 KB
Accession
0001251769-22-000023
Insider Transaction Report
Form 4/AAmended
Gutteridge Mike
VP, Int'l Sales and Marketing
Transactions
- Award
Common Stock
2022-02-25+22,610→ 63,809 total - Award
Stock Option (Right to Buy)
2022-02-25+11,611→ 11,611 totalExercise: $5.63Exp: 2032-02-25→ Common Stock (11,611 underlying)
Footnotes (3)
- [F1]Represents the grant of Restricted Stock Units ("RSUs"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Issuer's 2017 Equity Incentive Plan (the "Plan"). The RSUs vest in equal annual installments over four years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Plan.
- [F2]The shares underlying the option shall vest as to 25% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following three years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Plan.
- [F3]The number of shares listed in this column does not include other outstanding equity awards granted with different exercise prices, vesting conditions and other terms.
Documents
Issuer
Apollo Endosurgery, Inc.
CIK 0001251769
Entity typeother
Related Parties
1- filerCIK 0001913992
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 5:53 PM ET
- Size
- 8.3 KB